REVIEW article
Front. Cell Dev. Biol.
Sec. Molecular and Cellular Pathology
Volume 13 - 2025 | doi: 10.3389/fcell.2025.1517121
Intestinal Organoids for Inflammatory Bowel Disease
Provisionally accepted- South China Hospital of Shenzhen University, Shenzhen, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Inflammatory bowel disease (IBD) is a chronic relapsing-remitting immune-mediated disorder affecting the gastrointestinal tract with unknown etiology, and its incidence is on the rise worldwide. IBD is related to five major factors: genetic susceptibility, immune dysregulation, intestinal epithelial mechanical barrier damage, intestinal microbial dysbiosis, and environmental stimulation. At a molecular level, intrinsic deficiencies in epithelial integrity, mucosal barrier function, and mechanisms of immune response and resolution contribute to the development of IBD. Intestinal epithelial repair and mucosal healing are the goals of IBD treatment, and play an important role in the pathogenesis and treatment of IBD. Intestinal organoids, are three-dimensional cellular structures that recapitulate the basic architecture and functional processes of the organ of origin, retain the genetic and transcriptomic profile of the tissue of origin, and provide a good in vitro model for the study of intestinal epithelium in IBD. Recent studies have revealed that functional disruption of the intestinal epithelium is closely related to the pathogenesis of IBD, and IBD research using organoids has attracted attention. In this review, we describe the origin of intestinal organoids and summarize the application and progress of this technology in IBD research.
Keywords: intestinal organoids, inflammatory bowel disease, application, progress, new therapies
Received: 28 Oct 2024; Accepted: 21 Apr 2025.
Copyright: © 2025 Ren and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Silin Huang, South China Hospital of Shenzhen University, Shenzhen, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.